Chen Xiao-Dong, Dusevich Vladimir, Feng Jian Q, Manolagas Stavros C, Jilka Robert L
Division of Endocrinology and Metabolism, Center for Osteoporosis and Metabolic Bone Diseases, Central Arkansas Veterans Healthcare System, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
J Bone Miner Res. 2007 Dec;22(12):1943-56. doi: 10.1359/jbmr.070725.
We cultured MSCs on an ECM made by bone marrow cells to attempt to reconstitute the MSC niche. This ECM promoted replication of mesenchymal progenitors and retention of their multipotentiality. We conclude that the marrow ECM facilitates expansion of mesenchymal progenitors and hypothesize that it plays an important role in the maintenance of MSC stemness.
Mesenchymal colony-forming cells of the bone marrow comprise mesenchymal stem cells (MSCs) and their transit amplifying progeny, which we term mesenchymal colony-forming units (MCFUs). These progenitors undergo self-renewal and can differentiate into many different cell types including osteoblasts. However, they lose their unique properties when cultured on tissue culture plastic. This indicates that a critical feature of the marrow microenvironment that facilitates retention of stem cell properties is missing in such culture systems. In other tissues, the extracellular matrix (ECM) forms part of the specialized niche that controls stem cell behavior. Therefore, we examined whether a marrow cell-derived ECM promotes retention of the stem cell characteristics of MCFUs in vitro.
A cell-free ECM was prepared from cultured murine marrow adherent cells. The replication and multipotentiality of murine MCFUs maintained on this marrow cell-derived ECM were examined in vitro and in vivo and compared with the behavior of MCFUs maintained on plastic.
The marrow cell-derived ECM was made up of collagen types I, III, and V, syndecan-1, perlecan, fibronectin, laminin, biglycan, and decorin, similar to the composition of the marrow ECM. This ECM preparation promoted MCFU replication, restrained their "spontaneous" differentiation toward the osteoblast lineage, and preserved their ability to differentiate into osteoblasts or adipocytes. Moreover, transplantation of MCFUs expanded on the marrow cell-derived ECM into immunocompromised mice generated five times more bone and eight times more hematopoietic marrow compared with MCFUs expanded on plastic.
The marrow ECM facilitates expansion of MCFUs in vitro while preserving their stem cell properties. We hypothesize that the ECM made by bone marrow cells plays an important role in the maintenance of MSC function.
我们将间充质干细胞(MSCs)培养在由骨髓细胞制成的细胞外基质(ECM)上,试图重建MSC生态位。这种ECM促进了间充质祖细胞的增殖及其多能性的保留。我们得出结论,骨髓ECM促进了间充质祖细胞的扩增,并推测其在维持MSC干性中起重要作用。
骨髓间充质集落形成细胞包括间充质干细胞(MSCs)及其过渡扩增子代,我们将其称为间充质集落形成单位(MCFUs)。这些祖细胞进行自我更新,并可分化为许多不同的细胞类型,包括成骨细胞。然而,当它们在组织培养塑料上培养时会失去其独特特性。这表明在这种培养系统中缺少促进干细胞特性保留的骨髓微环境的关键特征。在其他组织中,细胞外基质(ECM)构成了控制干细胞行为的特殊生态位的一部分。因此,我们研究了骨髓细胞衍生的ECM是否能在体外促进MCFUs干细胞特性的保留。
从培养的小鼠骨髓贴壁细胞制备无细胞ECM。在体外和体内检测维持在这种骨髓细胞衍生的ECM上的小鼠MCFUs的增殖和多能性,并与维持在塑料上的MCFUs的行为进行比较。
骨髓细胞衍生的ECM由I型、III型和V型胶原、syndecan-1、基底膜聚糖、纤连蛋白、层粘连蛋白、双糖链蛋白聚糖和核心蛋白聚糖组成,与骨髓ECM的组成相似。这种ECM制剂促进了MCFU的增殖,抑制了它们向成骨细胞谱系的“自发”分化,并保留了它们分化为成骨细胞或脂肪细胞的能力。此外,与在塑料上扩增的MCFUs相比,将在骨髓细胞衍生的ECM上扩增的MCFUs移植到免疫缺陷小鼠中,产生的骨量多五倍,造血骨髓多八倍。
骨髓ECM在体外促进MCFUs的扩增,同时保留其干细胞特性。我们推测骨髓细胞制成的ECM在维持MSC功能中起重要作用。